Quick Takeaways
- This page summarizes Michael Egholm's Form 4 filing for STANDARD BIOTOOLS INC. (LAB).
- 2 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 21 May 2024, 17:37.
Michael Egholm - 20 May 2024 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)
- Signature
- /s/ Michael Egholm by Agnieszka Gallagher, Attorney-in-Fact
- Issuer symbol
- LAB
- Transactions as of
- 20 May 2024
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 21 May 2024, 17:37:39 UTC
- Previous filing
- 09 Apr 2024
- Next filing
- 05 Sep 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Michael Egholm filed Form 4 for STANDARD BIOTOOLS INC. (LAB) on 21 May 2024."
What Changed
- Previous filing in this sequence was filed on 09 Apr 2024.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LAB | Common Stock | Award | $0 | +1,000,000 | +188% | $0.000000 | 1,531,592 | 20 May 2024 | Direct | F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LAB | Stock Option (Right to Buy) | Award | $0 | +2,250,000 | $0.000000 | 2,250,000 | 20 May 2024 | Common Stock | 2,250,000 | $2.58 | Direct | F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Represents Restricted Stock Units ("RSUs") that vest as to 1/16th of the RSUs on August 20, 2024, with the remaining RSUs vesting in equally quarterly installments over four years thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting. |
| F2 | The Option becomes exercisable as to 1/16th of the underlying shares on August 20, 2024, with the remaining shares vesting in equal quarterly installments over four years thereafter, subject to the Reporting Person's continued service through the applicable vesting date. |